Acute blockade by endothelin-1 of haemodynamic insulin action in rats
- 23 December 2006
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 50 (2) , 443-451
Abstract
Plasma levels of endothelin-1 are frequently elevated in patients with hypertension, obesity and type 2 diabetes. We hypothesise that this vasoconstrictor may prevent full perfusion of muscle, thereby limiting delivery of insulin and glucose and contributing to insulin resistance.Keywords
This publication has 36 references indexed in Scilit:
- Endothelin antagonism improves hepatic insulin sensitivity associated with insulin signaling in Zucker fatty ratsMetabolism, 2005
- Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 productionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Metabolic and vascular actions of endothelin-1 are inhibited by insulin-mediated vasodilation in perfused rat hindlimb muscleBritish Journal of Pharmacology, 2005
- Quantification of hepatic microcirculation heterogeneity of perfusion: Effects of endothelin-1Microvascular Research, 2005
- Involvement of Endogenous Endothelin-1 in Exercise-Induced Redistribution of Tissue Blood FlowCirculation, 2002
- Exogenous endothelin‐1 causes peripheral insulin resistance in healthy humansActa Physiologica Scandinavica, 1997
- EndothelinsNew England Journal of Medicine, 1995
- Plasma endothelin levels in hypertension and chronic renal failure.Hypertension, 1990
- Effect of endothelin-1 in man.Circulation, 1990
- Regional Hemodynamic Effects of Endothelin-1 in Conscious, Unrestrained, Wistar RatsJournal of Cardiovascular Pharmacology, 1989